Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.85
0.62%
After-hours: Sep 18, 2025, 05:48 PM EDT

Dogwood Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
46.45K 29.2K 12.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-46.45K -29.2K -12.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-18.2M -15.34M -12.23M -5.82M -4.8M -5.2M -5.45M -6.4M -7.72M -9.91M -12.32M -14.41M -15.93M -16.54M -15.64M -17.88M -16.43M -12.68M
Interest Income
131.87K 40.48K 63.24K 98.2K 116.92K 133.25K 150.9K 115.95K 93.34K 61.83K 22.32K 22.32K 7.22K 3.91K 4.4K 4.4K 2.9K 1.4K
Pretax Income
-24.55M -21.79M -12.35M -5.73M -4.68M -5.07M -5.3M -6.24M -7.58M -9.8M -12.25M -14.71M -16.25M -16.86M -15.96M -17.95M -16.56M -12.94M
Net Income
-24.74M -21.98M -12.35M -5.73M -4.68M -5.07M -5.3M -6.24M -7.58M -9.8M -12.25M -14.71M -16.25M -16.86M -15.96M -17.95M -16.56M -12.94M
Selling & General & Admin
10.32M 9.7M 8.7M 4.31M 3.44M 3.63M 3.72M 3.7M 3.77M 4.11M 4.25M 4.7M 4.88M 4.69M 4.85M 9.97M 11.37M 10.81M
Research & Development
7.86M 5.62M 3.53M 1.51M 1.35M 1.57M 1.73M 2.7M 3.95M 5.8M 8.07M 9.72M 11.06M 11.86M 10.8M 7.91M 5.06M 1.87M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
18.18M 15.33M 12.23M 5.82M 4.8M 5.2M 5.45M 6.4M 7.72M 9.91M 12.32M 14.41M 15.93M 16.54M 15.64M 17.88M 16.43M 12.68M
Interest Expense
302.53K 302.53K 155.44K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 79.58K 184.02K 300.22K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.34M 6.48M 12.23M 5.82M 4.8M 5.2M 5.45M 6.4M 7.72M 9.91M 12.32M 14.41M 15.93M 16.54M 15.64M 17.88M 16.43M 12.68M
Income Tax Expense
190.19K 190.04K -503 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
1.91M 1.44M 1.31M 1.11M 916.03K 770.32K 770.32K 763.75K 736.46K 733.22K 733.22K 368K 333.21K 333.21K 333.21K 333.21K 333.21K 333.04K
Shares Outstanding (Diluted)
1.91M 1.44M 1.31M 1.11M 916.03K 770.32K 770.32K 763.75K 736.46K 733.22K 733.22K 368K 333.21K 333.21K 333.21K 333.21K 333.21K 333.04K
EPS (Basic)
-18.39 -17.55 -10.78 -6.31 -5.88 -6.69 -7.08 -8.44 -13.82 -22.87 -32.69 -43.44 -48.77 -50.61 -47.9 -65.54 -67.17 -57.71
EPS (Diluted)
-18.39 -17.55 -10.78 -6.31 -5.88 -6.69 -7.08 -8.44 -13.82 -22.87 -32.69 -43.44 -48.77 -50.61 -47.9 -65.54 -67.17 -57.71
EBITDA
-24.23M -21.51M -12.26M -5.82M -4.8M -5.2M -5.45M -6.4M -7.72M -9.91M -12.32M -14.41M -15.93M -16.54M -15.64M -17.88M -16.43M -12.68M
EBIT
-24.27M -21.53M -12.26M -5.82M -4.8M -5.2M -5.45M -6.4M -7.72M -9.91M -12.32M -14.41M -15.93M -16.54M -15.64M -17.88M -16.43M -12.68M
Depreciation & Amortization
34.28K 17.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a